The Journal of Immunology, Vol 135, Issue 6 4144-4148, Copyright © 1985 by American Association of Immunologists

ARTICLES

Cell mediated immunity in American cutaneous and mucosal leishmaniasis

EM Carvalho, WD Johnson, E Barreto, PD Marsden, JL Costa, S Reed and H Rocha

Cellular immune responses were studied in 35 Brazilian patients with either active cutaneous leishmaniasis (CL), active mucosal leishmaniasis (ML), or healed cutaneous leishmaniasis. The mean age and duration of illness in the two groups were as follows: 14 CL patients, age 28 +/- 13 yr, disease 5 +/- mo; and 16 ML patients, age 34 +/- 15 yr, disease 86 +/- 117 mo. Patients with CL and ML responded well to leishmania antigen in blastogenesis assays. However, the response of ML patients was over three times greater than the response of CL patients. There was a significant correlation between the magnitude of the lymphoproliferative response and the duration of disease activity. There were no significant differences between CL and ML patients in terms of the following parameters: lymphoproliferative responsiveness to mitogens (phytohemagglutinin, concanavalin A, and pokeweed mitogen) and peripheral blood lymphocyte subpopulations (T and B cells, oKT8+ and OKT4+ cells, OKT4:OKT8 ratio). Peripheral blood mononuclear cells from ML patients also generated interferon-gamma containing lymphokine in response to stimulation with leishmania antigen. This lymphokine was capable of inducing macrophages from ML patients to inhibit the intracellular multiplication of leishmania in vitro. These studies have determined that the parameters of lymphocyte and macrophage functions evaluated in ML and CL patients are comparable, except for an enhanced lymphoproliferative response, with leishmania antigen in ML patients. This later finding may be a function of the long duration of active disease in this population and unrelated to the pathogenesis of their mucosal lesions.

This article has been cited by other articles:

				C. Favali, N. Tavares, J. Clarencio, A. Barral, M. Barral-Netto, and C. Brodskyn Leishmania amazonensis infection impairs differentiation and function of human dendritic cells J. Leukoc. Biol., December 1, 2007; 82(6): 1401 - 1406. [Abstract] [Full Text] [PDF]

				D. R. Faria, K. J. Gollob, J. Barbosa Jr, A. Schriefer, P. R. L. Machado, H. Lessa, L. P. Carvalho, M. A. Romano-Silva, A. R. de Jesus, E. M. Carvalho, et al. Decreased In Situ Expression of Interleukin-10 Receptor Is Correlated with the Exacerbated Inflammatory and Cytotoxic Responses Observed in Mucosal Leishmaniasis Infect. Immun., December 1, 2005; 73(12): 7853 - 7859. [Abstract] [Full Text] [PDF]

				V. S. AMATO, H. F. ANDRADE JR., V. A. NETO, and M. I. S. DUARTE SHORT REPORT: PERSISTENCE OF TUMOR NECROSIS FACTOR-{alpha} IN SITU AFTER LESION HEALING IN MUCOSAL LEISHMANIASIS Am J Trop Med Hyg, May 1, 2003; 68(5): 527 - 528. [Abstract] [Full Text] [PDF]

				O. Bacellar, H. Lessa, A. Schriefer, P. Machado, A. Ribeiro de Jesus, W. O. Dutra, K. J. Gollob, and E. M. Carvalho Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients Infect. Immun., December 1, 2002; 70(12): 6734 - 6740. [Abstract] [Full Text] [PDF]

				A. M. Da-Cruz, R. Bittar, M. Mattos, M. P. Oliveira-Neto, R. Nogueira, V. Pinho-Ribeiro, R. B. Azeredo-Coutinho, and S. G. Coutinho T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after Therapy Clin. Vaccine Immunol., March 1, 2002; 9(2): 251 - 256. [Abstract] [Full Text] [PDF]

				M. L. B. Sousa-Atta, G. S. Salame, A. D'Oliveira Jr, R. P. Almeida, A. M. Atta, and E. M. Carvalho Immunoglobulin E Antileishmanial Antibody Response in Cutaneous Leishmaniasis Clin. Vaccine Immunol., January 1, 2002; 9(1): 101 - 104. [Abstract] [Full Text] [PDF]

				M. M. L. Pompeu, C. Brodskyn, M. J. Teixeira, J. Clarencio, J. Van Weyenberg, I. C. B. Coelho, S. A. Cardoso, A. Barral, and M. Barral-Netto Differences in Gamma Interferon Production In Vitro Predict the Pace of the In Vivo Response to Leishmania amazonensis in Healthy Volunteers Infect. Immun., December 1, 2001; 69(12): 7453 - 7460. [Abstract] [Full Text] [PDF]